1,320
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden

ORCID Icon, , , & ORCID Icon
Pages 556-564 | Received 18 Apr 2018, Accepted 30 Aug 2018, Published online: 15 Oct 2018

References

  • Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology. J Am Coll Cardiol. 2003;42:1493–1531.
  • Almendral J, Castellanos E, Ortiz M. Paroxysmal supraventricular tachycardias and preexcitation syndromes. Rev. Española Cardiol. (English Ed.) 2012;65:456–469.
  • Bhandari AK, Anderson JL, Gilbert EM, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J. 1992;124:381–386.
  • Clair WK, Wilkinson WE, McCarthy EA, et al. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation. 1993;87:1114–1122.
  • Wood K. a, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol. 1997;79:145–149.
  • Campbell RW. What happens to people with “supra” ventricular tachycardia? Eur Heart J. 1994;15 Suppl A:27–30.
  • Hays LJ, Lerman BB, DiMarco JP. Nonventricular arrhythmias as precursors of ventricular fibrillation in patients with out-of-hospital cardiac arrest. Am. Heart J. 1989;118:53–57.
  • Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18:1711–1719.
  • Timmermans C, Smeets JLRM, Rodriguez LM, et al. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492–494.
  • Brembilla-Perrot B, Delobelle J. Prevalence of stroke among patients with paroxysmal supraventricular tachycardia. Pacing Clin Electrophysiol. 2013;36:180–186.
  • Hamer ME, Wilkinson WE, Clair WK, et al. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 1995;25:984–988.
  • Kalbfleisch SJ, El-Atassi R, Calkins H, et al. Association between atrioventricular node reentrant tachycardia and inducible atrial flutter. J Am Coll Cardiol. 1993;22:80–84.
  • Khachab H, Brembilla-Perrot B. Prevalence of atrial fibrillation in patients with history of paroxysmal supraventricular tachycardia. Int J Cardiol. 2013;166:221–224.
  • Heinz G, Siostrzonek P, Kreiner G, et al. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol. 1992;69:489–492.
  • Blomstrom-Lundqvist C, Blomstrom P, Beckman-Suurkula M. Incessant ventricular tachycardia with a right bundle-branch block pattern and left axis deviation abolished by catheter manipulation. Pacing Clin Electro. 1990;13:11–16.
  • Orejarena LA, Vidaillet H, Jr.,DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31:150–157.
  • Gillette PC. The mechanisms of supraventricular tachycardia in children. Circulation 1976;54:133–139.
  • Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028–1032.
  • Abid L, Trabelsi I, Maazoun Y, et al. [Supraventricular tachycardia in infants]. Ann Cardiol Angeiol. 2011;60:141–147.
  • Calabro MP, Cerrito M, Luzza F, et al. Supraventricular tachycardia in infants: epidemiology and clinical management. CPD. 2008;14:723–728.
  • Balaji S. Supraventricular tachycardia in children. Curr Treat Options Cardio Med. 2000;2:521–528.
  • Kantoch MJ. Supraventricular tachycardia in children. Indian J Pediatr. 2005;72:609–619.
  • Rosen M, Hakulinen T. Use of disease registers. In: W. Ahrens, I. Pigeot, editors. Handbook of epidemiology. Berlin: Springer-Verlag; 2005. p. 231–252.
  • Zöller B. Nationwide family studies of cardiovascular diseases – clinical and genetic implications of family history. EMJ Cardiol. 2013;1:102–113.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
  • National Board of Health and Welfare. Validity of the Diagnoses from the Swedish in-Care Register 1987 and 1995. Stockholm: National Board of Health and Welfare; 2000.
  • Smith JG, Platonov PG, Hedblad B, et al. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25:95–102.
  • Ingelsson E, Ärnlöv J, Sundström J, et al. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787–791.
  • Rothman KJ, Boice HD, Austin H. Epidemiologic analysis with a programmable calculator. 2nd ed. Boston, MA: Epidemiology Resources, Incorporated; 1982.
  • Krumholz HM, Normand S-LT, Wang Y. Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999–2011. Circulation. 2014;130:966–975.
  • Manolio TA, Furberg CD, Rautaharju PM, et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol. 1994;23:916–925.
  • Brembilla-Perrot B, Sellal JM, Olivier A, et al. Influence of advancing age on clinical presentation, treatment efficacy and safety, and long-term outcome of inducible paroxysmal supraventricular tachycardia without pre-excitation syndromes: a cohort study of 1960 patients included over 25 years. PLoS One 2018;13:e0187895.
  • Romer M, Candinas R. Adenosine-induced non-sustained polymorphic ventricular tachycardia. Eur Heart J. 1994;15:281–282.
  • Shiraishi H, Ishibashi K, Urao N, et al. Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia. Intern Med. 2002;41:445–448.
  • Mattia LD, Brieda M, Bianco FD, et al. Polymorphic ventricular tachycardia induced by Valsalva manoeuvre in a patient with paroxysmal supraventricular tachycardia. Europace. 2012;14:767–768.